# ProHance

NDC: 0270-1111
Generic name: gadoteridol
Labeler / Manufacturer: BRACCO DIAGNOSTICS INC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 19921116

FDA application: NDA020131

## Active ingredients

- GADOTERIDOL: 279.3 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0270-1111"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0270-1111
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=778aee03-7d4c-481a-be8a-a75db0702f5a